“We have been moving in the direction of thinking about CRISPR as a platform for some years,” said Jennifer Doudna, a professor, Nobel laureate and founder of the Innovative Genomics Institute. The article also quotes Fyodor Urnov, a scientific director of the institute.

Fyodor Urnov is part of the team that worked on a novel, on-demand CRISPR theray to treat a newborn boy diagnosed at birth with a rare and potentially fatal genetic disease. 

“We made all three major groups of human milk oligosaccharides,” said Patrick Shih, an assistant professor in the Department of Plant & Microbial Biology.

With a millennia-long record of ritual and ceremonial use, psilocybin's potential to treat certain mental disorders has seen new research interest.

Nobel laureate and Professor Jennifer Doudna will oversee the new center’s work alongside Fyodor Urnov, Doudna’s fellow Berkeley professor.